13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001600004
Total reported value
$1.6B
$1.6B
36 檔
24.2%
The Q4 2024 SEC filing reveals that First Light Asset Management, LLC held a total portfolio value of $1.6B, covering 36 public equity positions.
In Q4 2024, First Light Asset Management, LLC adopted a defensive or profit-taking posture, trimming 18 positions and completely liquidating 11 holdings to manage risk exposure.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | FNAUSD | Paragon 28 Inc | Stock-Other | 10.46% | — | +4.19% | |
| 2 | 260 | Centessa Pharmaceuticals-adr | Stock-Other | 9.30% | -5.56% | EXIT | |
| 3 | AXGN | Axogen Inc | Stock-Other | 7.11% | -4.16% | +10.18% | |
| 4 | ATRC | Atricure Inc | Stock-Other | 5.76% | -0.90% | +5.56% | |
| 5 | TWST | Twist Bioscience CORP | Stock-Other | 5.45% | +0.81% | — | |
| 6 | VERA | Vera Therapeutics Inc | Stock-Other | 5.10% | -1.13% | EXIT | |
| 7 | NEO | Neogenomics Inc | Stock-Healthcare | 4.99% | +4.42% | +2.96% | |
| 8 | XENE | Xenon Pharmaceuticals Inc | Stock-Other | 4.35% | — | -1.78% | |
| 9 | CRNX | Crinetics Pharmaceuticals In | Stock-Other | 4.33% | -0.45% | -6.16% | |
| 10 | IRTC | Irhythm Holdings Inc | Stock-Healthcare | 3.71% | -0.57% | — | |
| 11 | HCAT | Health Catalyst Inc | Stock-Other | 3.55% | +0.08% | +21.99% | |
| 12 | PFMTUSD | Performant Financial CORP | Stock-Other | 3.28% | — | +1.22% | |
| 13 | INSM | Insmed Inc | Stock-Healthcare | 3.11% | — | -31.75% | |
| 14 | MDXG | Mimedx Group Inc | Stock-Other | 3.08% | -1.01% | EXIT | |
| 15 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 3.07% | — | +1.13% | |
| 16 | KRMD | Koru Medical Systems Inc | Stock-Other | 2.18% | -0.60% | +5.65% | |
| 17 | PLRX | Pliant Therapeutics Inc | Stock-Other | 2.12% | — | -34.73% | |
| 18 | EWTX | Edgewise Therapeutics Inc | Stock-Other | 1.99% | -0.13% | — | |
| 19 | JANX | Janux Therapeutics Inc | Stock-Other | 1.61% | — | — | |
| 20 | SIBN | Si-bone Inc | Stock-Other | 1.53% | +2.00% | -25.50% | |
| 21 | KYMR | Kymera Therapeutics Inc | Stock-Other | 1.48% | — | -5.67% | |
| 22 | NTRA | Natera Inc | Stock-Healthcare | 1.41% | — | -49.67% | |
| 23 | BFLY | Butterfly Network Inc | Stock-Other | 1.19% | +0.39% | — | |
| 24 | RGEN | Repligen CORP | Stock-Healthcare | 1.14% | — | -50.29% | |
| 25 | ANAB | Anaptysbio Inc | Stock-Other | 1.10% | -0.42% | -8.36% | |
| 26 | GPCR | Structure Therapeutics Inc | Stock-Other | 1.03% | — | -21.21% | |
| 27 | TNDM | Tandem Diabetes Care Inc | Stock-Other | 1.01% | +0.84% | -71.51% | |
| 28 | DYN | Dyne Therapeutics Inc | Stock-Other | 0.95% | — | -66.56% | |
| 29 | ELDN | Eledon Pharmaceuticals Inc | Stock-Other | 0.92% | — | — | |
| 30 | GH | Guardant Health Inc | Stock-Healthcare | 0.90% | +1.71% | -52.33% | |
| 31 | PODD | Insulet CORP | Stock-Healthcare | 0.84% | — | -78.74% | |
| 32 | TMDX | Transmedics Group Inc | Stock-Healthcare | 0.83% | — | -47.41% | |
| 33 | OSCR | Oscar Health Inc - Class A | Stock-Healthcare | 0.70% | — | -69.03% | |
| 34 | SENS1GBP | Senseonics Holdings Inc | Stock-Other | 0.32% | — | — | |
| 35 | EVH | Evolent Health Inc - A | Stock-Other | 0.06% | — | -97.67% | |
| 36 | IWO | Ishares Russell 2000 Growth | ETF-Small Cap | 0.03% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | TWST | Twist Bioscience CORP | +5.5% | NEW | New buy |
| 2 | FNAUSD | Paragon 28 Inc | +4.8% | +4.19% | Add |
| 3 | IRTC | Irhythm Holdings Inc | +3.7% | NEW | New buy |
| 4 | MDXG | Mimedx Group Inc | +3.1% | NEW | New buy |
| 5 | VERA | Vera Therapeutics Inc | +2.5% | +78.84% | Add |
| 6 | AXGN | Axogen Inc | +2.3% | +10.18% | Add |
| 7 | EWTX | Edgewise Therapeutics Inc | +2% | NEW | New buy |
| 8 | JANX | Janux Therapeutics Inc | +1.6% | NEW | New buy |
| 9 | ATRC | Atricure Inc | +1.4% | +5.56% | Add |
| 10 | 260 | Centessa Pharmaceuticals-adr | +1.4% | -2.27% | Trim |
| 11 | NEO | Neogenomics Inc | +1.2% | +2.96% | Add |
| 12 | BFLY | Butterfly Network Inc | +1.2% | NEW | New buy |
| 13 | ELDN | Eledon Pharmaceuticals Inc | +0.9% | NEW | New buy |
| 14 | KRMD | Koru Medical Systems Inc | +0.9% | +5.65% | Add |
| 15 | HCAT | Health Catalyst Inc | +0.6% | +21.99% | Add |
| 16 | XENE | Xenon Pharmaceuticals Inc | +0.5% | -1.78% | Trim |
| 17 | SENS1GBP | Senseonics Holdings Inc | +0.3% | NEW | New buy |
| 18 | CRNX | Crinetics Pharmaceuticals In | +0.3% | -6.16% | Trim |
| 19 | IWO | Ishares Russell 2000 Growth | 0% | NEW | New buy |
| 20 | ✓ | 0% | EXIT | Sold out | |
| 21 | ATEC | Alphatec Holdings Inc | -0.1% | EXIT | Sold out |
| 22 | KYMR | Kymera Therapeutics Inc | -0.1% | -5.67% | Trim |
| 23 | PFMTUSD | Performant Financial CORP | -0.2% | +1.22% | Add |
| 24 | SIBN | Si-bone Inc | -0.3% | -25.50% | Trim |
| 25 | PLRX | Pliant Therapeutics Inc | -0.3% | -34.73% | Trim |
| 26 | GH | Guardant Health Inc | -0.3% | -52.33% | Trim |
| 27 | EXK | Exact Sciences CORP | -0.4% | EXIT | Sold out |
| 28 | RARE | Ultragenyx Pharmaceutical In | -0.4% | +1.13% | Add |
| 29 | NTRA | Natera Inc | -0.5% | -49.67% | Trim |
| 30 | NARIUSD | Inari Medical Inc | -0.6% | EXIT | Sold out |
| 31 | ASND | Ascendis Pharma A/S | -0.6% | EXIT | Sold out |
| 32 | MOH | Molina Healthcare Inc | -0.8% | EXIT | Sold out |
| 33 | AVTR | Avantor Inc | -0.8% | EXIT | Sold out |
| 34 | GPCR | Structure Therapeutics Inc | -0.8% | -21.21% | Trim |
| 35 | RGEN | Repligen CORP | -0.9% | -50.29% | Trim |
| 36 | RLAY | Relay Therapeutics Inc | -0.9% | EXIT | Sold out |
| 37 | INSM | Insmed Inc | -1.1% | -31.75% | Trim |
| 38 | OPRX | Optimizerx CORP | -1.2% | EXIT | Sold out |
| 39 | ANAB | Anaptysbio Inc | -1.5% | -8.36% | Trim |
| 40 | BCYC | Bicycle Therapeutics Plc-adr | -1.8% | EXIT | Sold out |
| 41 | PODD | Insulet CORP | -2.2% | -78.74% | Trim |
| 42 | OSCR | Oscar Health Inc - Class A | -2.4% | -69.03% | Trim |
| 43 | TNDM | Tandem Diabetes Care Inc | -2.6% | -71.51% | Trim |
| 44 | PPHMEUR | Avid Bioservices Inc | -2.6% | EXIT | Sold out |
| 45 | TMDX | Transmedics Group Inc | -2.6% | -47.41% | Trim |
| 46 | DYN | Dyne Therapeutics Inc | -2.8% | -66.56% | Trim |
| 47 | EVH | Evolent Health Inc - A | -5.4% | -97.67% | Trim |
According to official SEC Form 13F filings, First Light Asset Management, LLC reported a total U.S. public equity portfolio value of $1.6B across 36 disclosed positions in Q4 2024.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including FNAUSD, 260, AXGN) accounted for 24.2% of total reported equity market value during Q4 2024.
Top New Position Initiated
TWST
市值: $57.0M
Top Position Liquidated / Trimmed
PPHMEUR
前期市值: $31.5M
During Q4 2024, First Light Asset Management, LLC's top holdings by market value included FNAUSD (10.5%)、260 (9.3%)、AXGN (7.1%). The largest single position, FNAUSD, represented 10.5% of total portfolio value.
In Q4 2024, First Light Asset Management, LLC made 47 total portfolio adjustments, initiating 9 new buys, adding to 9 positions, trimming 18 holdings, and fully liquidating 11 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.